# Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Notice a63ab723a93d4ac5952e6b64222262ab (solicitation 75A50126R00001_RFP_NPIVS_27) from HEALTH AND HUMAN SERVICES, DEPARTMENT OF, BARDA - ASPR / DAAPPO / BARDA DCMA, posted 2026-10-26, responses due 2026-11-20T22:00:00.000Z. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | a63ab723a93d4ac5952e6b64222262ab |
| Solicitation number | 75A50126R00001_RFP_NPIVS_27 |
| Type | Solicitation |
| Agency | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Sub-tier | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| Posted | 2026-10-26T19:59:56.000Z |
| Response deadline (UTC) | 2026-11-20T22:00:00.000Z |
| Set-aside | No Set aside used |
| NAICS | 541714 |
| PSC | AN12 |
| Place of performance | Washington, DC, USA |
| Award | - |

## Description

BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.

## Sources

- View on SAM.gov: https://sam.gov/opp/a63ab723a93d4ac5952e6b64222262ab/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response, SAM.gov contract opportunity a63ab723a93d4ac5952e6b64222262ab." samgovapi.io, https://samgovapi.io/opportunity/a63ab723a93d4ac5952e6b64222262ab, data as of 2026-11-14. Primary record: https://sam.gov/opp/a63ab723a93d4ac5952e6b64222262ab/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/a63ab723a93d4ac5952e6b64222262ab
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot